Evidence map›Paper›PMID 23859810›Full record

ArticleCytokine2013

Regulation of ADAMTS-1, -4 and -5 expression in human macrophages: differential regulation by key cytokines implicated in atherosclerosis and novel synergism between TL1A and IL-17.

Tim G Ashlin, Alvin P L Kwan, Dipak P Ramji

Open access · hybridAbstract read
In one paragraph

Article in Cytokine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Treatment of DystrophicBiomolecules · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Tim G AshlinCardiff School of Biosciences, Cardiff University, Sir Martin Evans Building, Museum Avenue, Cardiff CF10 3AX, United Kingdom.
Alvin P L Kwan
Dipak P Ramji
Cardiff University · GB

Funding

Biotechnology and Biological Sciences Research Council BB/D526137/1
6 · The paper itself

Abstract

Atherosclerosis is an inflammatory disease of the vasculature regulated by cytokines. Macrophages play a crucial role at all stages of this disease, including regulation of foam cell formation, the inflammatory response and stability of atherosclerotic plaques. For example, matrix metalloproteinases produced by macrophages play an important role in modulating plaque stability. More recently, the ADAMTS proteases, which are known to play a key role in the control of cartilage degradation during arthritis, have been found to be expressed in atherosclerotic lesions and suggested to have potentially important functions in the control of plaque stability. Unfortunately, the action of cytokines on the expression of ADAMTS family in macrophages is poorly understood. We have investigated the effect of classical cytokines (IFN-γ and TGF-β) and those that have been recently identified (TL1A and IL-17) on the expression of ADAMTS-1, -4 and -5 in human macrophages. The expression of all three ADAMTS members was induced during differentiation of monocytes into macrophages. TGF-β had a differential action with induction of ADAMTS-1 and -5 expression and attenuation in the levels of ADAMTS-4. In contrast, IFN-γ suppressed the expression of ADAMTS-1 without having an effect on ADAMTS-4 and -5. Although TL-1A or IL-17A alone had little effect on the expression of all the members, they induced their expression synergistically when present together. These studies provide new insight into the regulation of key ADAMTS family members in human macrophages by major cytokines in relation to atherosclerosis.

Indexed as

ADAM ProteinsADAMTS1 ProteinADAMTS4 ProteinADAMTS5 ProteinAtherosclerosisCell DifferentiationCell Line, TumorHumansInterferon-gammaInterleukin-17MacrophagesMonocytesPlaque, AtheroscleroticProcollagen N-EndopeptidaseTransforming Growth Factor betaTumor Necrosis Factor Ligand Superfamily Member 15ADAM ProteinsADAMTS1 ProteinADAMTS1 protein, humanADAMTS4 ProteinADAMTS4 protein, humanADAMTS5 ProteinADAMTS5 protein, humanInterferon-gammaInterleukin-17Procollagen N-EndopeptidaseTNFSF15 protein, humanTransforming Growth Factor betaTumor Necrosis Factor Ligand Superfamily Member 15ADAMTSADAMTS proteasesa disintegrin and metalloproteinase with thrombospondin motifsApoBApoEapolipoprotein Bapolipoprotein EAtherosclerosisCytokinesdeath receptor 3DR3ECMextracellular matrixGAPDHGene expressionglyceraldehyde-3-phosphate dehydrogenaseHMDMhuman monocyte-derived macrophagesIFN-γILinterferon-γinterleukinLDLLDLRLDL receptorlipoprotein lipaselow-density lipoproteinLPLMacrophagesmatrix metalloproteinaseMMPphorbol 12-myristate 13-acetatePMAreal-time quantitative polymerase chain reactionRT-qPCRTGF-βTL1ATNF-αtransforming growth factor-βtumour necrosis factor-like protein 1Atumour necrosis factor-αvascular smooth muscle cellsVSMC

Identifiers

PMID23859810
PMCPMC3779352
OpenAlexW2025103085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.